China Meheco Group Co (SHSE:600056) ROCE %

: 5.69% (As of Sep. 2023)

View and export this data going back to 1997. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. China Meheco Group Co's annualized ROCE % for the quarter that ended in Sep. 2023 was 5.69%.

China Meheco Group Co ROCE % Historical Data

The historical data trend for China Meheco Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Meheco Group Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

20.80

13.98

14.35

6.86

7.96

China Meheco Group Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															6.56	1.14	9.65	10.24	5.69

China Meheco Group Co ROCE % Calculation

China Meheco Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	1413.708	/	( ( (31110.549 - 13497.075)	+	(35898.613 - 18012.745) )	/ 2 )
	=	1413.708	/	( (17613.474	+	17885.868)	/ 2 )
	=	1413.708	/	17749.671
	=	7.96 %

China Meheco Group Co's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	1103.304	/	( ( (39457.328 - 19834.099)	+	(38186.205 - 19038.387) )	/ 2 )
	=	1103.304	/	( ( 19623.229	+	19147.818 )	/ 2 )
	=	1103.304	/	19385.5235
	=	5.69 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

China Meheco Group Co (SHSE:600056) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

China Meheco Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of China Meheco Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Meheco Group Co (SHSE:600056) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China Meheco Group Co Ltd (SHSE:600056) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 18 Guangming Zhongjie, Dongcheng District, Beijing, CHN, 100061

Website

http://www.meheco.com

China Meheco Group Co Ltd is engaged in the distribution and trading of botanical medicines, medical instruments, and pharmaceuticals. It offers botanic medicines and herbal products, as well as exports of natural medicines, including herbs, spices, plant extracts, bee products, Chinese traditional medicines. The company's business scope covers the whole industry chain, from research and development, cultivation and processing, manufacturing, distribution, logistics to international trading, academic promotion and technical service. The corporation provides trading services for customers in the pharmaceutical and chemical field, covering APIs, preparations, biologicals, blood products and others.

China Meheco Group Co (SHSE:600056) Headlines

No Headlines